Democratizing simulations in healthcare
QT/TdP Risk Screen
A new assessment tool for the preclinical screening of drug compounds. QT/TdP Risk Screen will help you to spot potential clinical drug-induced cardiac safety risks based on CredibleMeds classification and to identify safe concentration ranges for your compounds. Provided by Universitat Politècnica de València (UPV, Valencia) and Fundació Institut Mar D'Investigacions Mèdiques (FIMIM, Barcelona).
A new assessment tool for the preclinical screening of drug compounds. STrhiPS will help you to reconstruct the human ventricular action potential by means of in silico cellular studies performed on a population of human induced Pluripotent Stem Cell-Cardiomyocytes (hiPSC-CMs) to predict the proarrhythmic liability of your compounds. Provided by Bologna University (UniBo, Bologna) and Tampere University (TAU, Tampere).
Find out more about the interactions between implanted medical devices and the magnetic resonance imaging (MRI). With NuMRis - Numeric Magnetic Resonance implant testing, you will be able to simulate the behavior of the medical device (e.g. stent, hip prosthesis, 3D printed implant) during an MRI scan, to analyze the effects on the patient, and to quantify the dose and thermal outcomes due to the exposure.
CONSELF is a cloud platform designed to allows healthcare companies to perform computational fluid dynamic (CFD) and finite element model (FEM) analysis through a Software as a Service (SaaS) access in pay-per-use mode. Now you can analyze your ideas, maximize performance, estimate durability and safety, evaluate stresses and deformations and much more in a flexible and cost-effective way. The platform can be used both as a general-purpose simulation solver or through guided workflows to perform In Silico reproduction of standardized testing to evaluate design alternatives and identify worst-case scenarios before prototyping.